Bonesupport Holding AB (publ) (BONEX.ST)

SEK 382.8

(2.03%)

Revenue Summary of Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)'s latest annual revenue in 2023 was 591.07 Million SEK , up 79.76% from previous year.
Bonesupport Holding AB (publ)'s latest quarterly revenue in 2024 Q2 was 219.79 Million SEK , up 19.18% from previous quarter.
Bonesupport Holding AB (publ) reported a annual revenue of 328.81 Million SEK in annual revenue 2022, up 54.46% from previous year.
Bonesupport Holding AB (publ) reported a annual revenue of 212.88 Million SEK in annual revenue 2021, up 17.71% from previous year.
Bonesupport Holding AB (publ) reported a quarterly revenue of 184.41 Million SEK for 2024 Q1, up 6.76% from previous quarter.
Bonesupport Holding AB (publ) reported a quarterly revenue of 219.79 Million SEK for 2024 Q2, up 19.18% from previous quarter.

Annual Revenue Chart of Bonesupport Holding AB (publ) (2023 - 2014)

Historical Annual Revenue of Bonesupport Holding AB (publ) (2023 - 2014)

Year	Revenue	Revenue Growth
2023	591.07 Million SEK	79.76%
2022	328.81 Million SEK	54.46%
2021	212.88 Million SEK	17.71%
2020	180.86 Million SEK	16.34%
2019	155.46 Million SEK	60.9%
2018	96.62 Million SEK	-25.27%
2017	129.3 Million SEK	23.62%
2016	104.59 Million SEK	69.38%
2015	61.75 Million SEK	50.77%
2014	40.96 Million SEK	0.0%

Year	Revenue	Revenue Growth
2024 Q3	237.5 Million SEK	8.06%
2024 Q1	184.41 Million SEK	6.76%
2024 Q2	219.79 Million SEK	19.18%
2023 Q2	140.38 Million SEK	17.24%
2023 Q4	172.74 Million SEK	9.19%
2023 FY	591.07 Million SEK	79.76%
2023 Q1	119.74 Million SEK	16.01%
2023 Q3	158.2 Million SEK	12.69%
2022 Q3	84.62 Million SEK	13.39%
2022 Q4	103.22 Million SEK	21.98%
2022 FY	328.81 Million SEK	54.46%
2022 Q2	74.63 Million SEK	12.5%
2022 Q1	66.34 Million SEK	8.05%
2021 Q2	51.77 Million SEK	15.5%
2021 Q4	61.4 Million SEK	11.89%
2021 Q1	44.82 Million SEK	-15.7%
2021 FY	212.88 Million SEK	17.71%
2021 Q3	54.87 Million SEK	5.99%
2020 Q1	43.43 Million SEK	-5.99%
2020 FY	180.86 Million SEK	16.34%
2020 Q4	53.17 Million SEK	10.6%
2020 Q3	48.07 Million SEK	32.9%
2020 Q2	36.17 Million SEK	-16.71%
2019 Q1	32.82 Million SEK	42.06%
2019 FY	155.46 Million SEK	60.9%
2019 Q4	46.19 Million SEK	18.11%
2019 Q3	39.11 Million SEK	4.81%
2019 Q2	37.32 Million SEK	13.68%
2018 Q4	23.1 Million SEK	62.21%
2018 FY	96.62 Million SEK	-25.27%
2018 Q1	31.08 Million SEK	14.96%
2018 Q2	28.18 Million SEK	-9.33%
2018 Q3	14.24 Million SEK	-49.45%
2017 Q3	32.67 Million SEK	-12.0%
2017 Q1	32.45 Million SEK	9.52%
2017 Q2	37.13 Million SEK	14.41%
2017 Q4	27.03 Million SEK	-17.25%
2017 FY	129.3 Million SEK	23.62%
2016 Q2	25.16 Million SEK	8.25%
2016 FY	104.59 Million SEK	69.38%
2016 Q4	29.63 Million SEK	11.62%
2016 Q3	26.54 Million SEK	5.48%
2016 Q1	23.25 Million SEK	0.0%
2015 FY	61.75 Million SEK	50.77%
2014 FY	40.96 Million SEK	0.0%

Peer Revenue Comparison of Bonesupport Holding AB (publ)

Name	Revenue	Revenue Difference
AddLife AB (publ)	9.68 Billion SEK	93.897%
Biotage AB (publ)	1.86 Billion SEK	68.256%
Doxa AB (publ)	9.9 Million SEK	-5870.475%
Elekta AB (publ)	18.11 Billion SEK	96.738%
iZafe Group AB (publ)	1.82 Million SEK	-32341.109%
Ortivus AB (publ)	84.08 Million SEK	-602.985%
Ortivus AB (publ)	84.08 Million SEK	-602.985%
Q-linea AB (publ)	4.44 Million SEK	-13212.545%
S2Medical AB (publ)	6.97 Million SEK	-8378.664%
Synsam AB (publ)	5.9 Billion SEK	89.99%